Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
Clinical trial NCT05572658 · COMPLETED
Trial details
- NCT number
- NCT05572658
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-15
- Primary completion
- 2023-09-30
- Enrollment
- 10994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.